Advertisement

Acta Diabetologica

, Volume 28, Issue 2, pp 174–178 | Cite as

High glucose levels do not directly impair cellular binding of HDL3 or HDL-mediated efflux of cholesterol from human skin fibroblasts

  • P. B. Duell
  • E. L. Bierman
Originals

Abstract

The excess risk of atherosclerosis that is associated with diabetes mellitus cannot be completely accounted for by other known risk factors. Recent studies have suggested that increased glycation of high density lipoproteins (HDL) at high glucose concentrations causes functional abnormalities that might contribute to accelerated atherosclerosis. Other investigators also have shown that elevated glucose concentrations can stimulate the activity of protein kinase C in cultured cells. Because protein kinase C appears to be involved in HDL receptor-mediated efflux, the hypothesis that a high glucose concentration in vitro might modulate HDL-mediated efflux of cholesterol from human fibroblasts was tested. These studies indicate that a high glucose level alone does not affect the interaction of normal HDL3 with cultured human skin fibroblasts.

Key words

HDL3 Cholesterol efflux Cultured cells Hyperglycaemia Diabetes mellitus 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Witztum JL, Fisher M, Pietro T, Steinbrecher UP, Elam RL, Nonenzymatic glucosylation of high density lipoprotein accelerates its catabolism in guinea pigs. Diabetes 31:1029–1032, 1982Google Scholar
  2. 2.
    Duell PB, Oram JF, Bierman EL, Nonenzymatic glycosylation of HDL resulting in inhibition of high affinity binding to cultured human fibroblasts. Diabetes 39:1257–1263, 1990Google Scholar
  3. 3.
    Duell PB, Oram JF, Bierman EL, Nonenzymatic glycosylation of HDL and impaired HDL-receptor-mediated cholesterol efflux. Diabetes 40:377–384, 1991Google Scholar
  4. 4.
    Duell PB, Bierman EL, Diabetic HDL has reduced capacity to promote HDL receptor-mediated cholesterol efflux. Arteriosclerosis 10: 768A, 1990; Circulation 82:III-327, 1990Google Scholar
  5. 5.
    Curtiss LK, Witztum JL, Plasma apolipoproteins A-I, A-II, B, C-I, and E are glucosylated in hyperglycaemic diabetic subjects. Diabetes 34:452–461, 1985Google Scholar
  6. 6.
    Lee T-S, Saltsman KA, Ohashi H, King GL, Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci USA 86:5141–5145, 1989Google Scholar
  7. 7.
    Lee T-S, MacGregor LC, Fluharty SJ, King GL, Differential regulation of protein kinase C and (Na,K)-adenosine triphosphate activities by elevated glucose levels in retinal capillary endothelial cells. J Clin Invest 83:90–94, 1989Google Scholar
  8. 8.
    Craven PA, Davidson CM, DeRubertis FR, Increase in diacylglycerol mass in isolated glomeruli by glucose from de novo synthesis of glycerolipids. Diabetes 39:667–674, 1990Google Scholar
  9. 9.
    Draznin B, Leitner JW, Sussman KE, Sherman NA, Insulin and glucose modulate protein kinase C activity in rat adipocytes. Biochem Biophys Res Commun 156:570–575, 1988Google Scholar
  10. 10.
    Ishizuka T, Hoffman J, Cooper DR, Watson JE, Pushkin DB, Farese RV, Glucose induced synthesis of diacylglycerol de novo is associated with translocation (activation) of protein kinase C in rat adipocytes. FEBS Lett 249:234–238, 1989Google Scholar
  11. 11.
    Mendez AM, Oram JF, Bierman EL, Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J Biol Chem 266:10104–10111, 1991Google Scholar
  12. 12.
    Oram JF, Effects of high density lipoprotein subfractions on cholesterol homeostasis in human fibroblasts and arterial smooth muscle cells. Arteriosclerosis 3:420–432, 1983Google Scholar
  13. 13.
    Oppenheimer MJ, Oram JF, Bierman EL, Downregulation of high density lipoprotein receptor activity of cultured fibroblasts by platelet-derived growth factor. Arteriosclerosis 7:325–332, 1987Google Scholar
  14. 14.
    Bilheimer PW, Eisenberg S, Levy RI, The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta 260:212–221, 1972Google Scholar
  15. 15.
    Bierman EL, Stein O, Stein Y, Lipoprotein uptake and metabolism by rat aortic smooth, muscle cells in tissue culture. Circ Res 35:136–150, 1979Google Scholar
  16. 16.
    Slotte JP, Oram JF, Bierman EL, Binding of high density lipoproteins to cell receptors promotes translocation of cholesterol from intracellular membranes to the cell surface. J Biol Chem 262:12904–12907, 1987Google Scholar
  17. 17.
    Oram JF, Slotte JP, Aviram M, Duell PB, Graham DS, Bierman EL, High density lipoprotein receptor-mediated transport of excess cholesterol from cells. In: Miller NE (ed) High density lipoproteins, reverse cholesterol transport, and coronary heart disease. Excerpta Medica, Princeton, Elsevier, pp 5–13, 1989Google Scholar
  18. 18.
    Oppenheimer MJ, Oram JF, Bierman EL, Up-regulation of high density lipoprotein receptor activity by gamma-interferon associated with inhibition of cell proliferation. J Biol Chem 263:19318–19323, 1988Google Scholar
  19. 19.
    Heider JG, Bayett RL, The picomole determination of free and total cholesterol in cells in culture. J Lipid Res 19:514–518, 1978Google Scholar
  20. 20.
    Oppenheimer MJ, Sundquist K, Bierman EL, Downregulation of high-density lipoprotein receptor in human fibroblasts by insulin and IGF-I. Diabetes 38:117–122, 1989Google Scholar
  21. 21.
    Jialal I, Chait A, Pathogenesis of microangiopathy in diabetes. In: Draznin B, Melmed B, LeRoith S (eds) Molecular and cellular biology of diabetes mellitus: complications of diabetes mellitus. Liss, New York, pp 69–75, 1988Google Scholar
  22. 22.
    Chait A, Bierman EL, Brunzell JD, Diabetic macroangiopathy. In: Alberti KG, Krall LP (eds) The diabetes annual/I. Elsevier, Amsterdam, pp 323–348, 1985Google Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • P. B. Duell
    • 1
  • E. L. Bierman
    • 1
  1. 1.Division of Metabolism, Endocrinology, and NutritionSeattleUSA

Personalised recommendations